Privia Health Group (NASDAQ:PRVA) Shares Break Above 200 Day Moving Average – Should You Sell?

Privia Health Group, Inc. (NASDAQ:PRVA)’s share price passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $22.63 and traded as high as $23.98. Privia Health Group shares last traded at $23.94, with a volume of 3,338,673 shares changing hands.

Key Headlines Impacting Privia Health Group

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia reported Q3 earnings of $0.21 per share, above the $0.09 consensus estimate, and revenue of $656.96 million versus expectations of $610.72 million. Revenue rose 13.2% year over year. Privia Health Q3 results
• Positive Sentiment: The company raised full-year 2026 guidance across all key financial metrics. Year-to-date adjusted EBITDA was $114.7 million, up 21.9% from the same period in 2025, supporting the improved outlook. Privia Health Q3 results
• Positive Sentiment: Canaccord Genuity raised its price target from $32 to $33 and maintained a Buy rating. Piper Sandler raised its target from $36 to $38 and kept an Overweight rating, signaling increased analyst confidence. Canaccord Genuity price-target update Piper Sandler ratings
• Positive Sentiment: A valuation analysis argued that PRVA could be undervalued following its earnings beat, adding to the positive post-results narrative. Privia Health valuation analysis
• Negative Sentiment: Despite beating estimates, reported quarterly EPS of $0.21 was below the $0.29 reported a year earlier, a potential caveat for investors weighing the strong revenue growth and raised guidance.

Analysts Set New Price Targets

A number of brokerages have commented on PRVA. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Piper Sandler boosted their target price on shares of Privia Health Group from $36.00 to $38.00 and gave the stock an “overweight” rating in a research note on Friday. Canaccord Genuity Group upped their target price on shares of Privia Health Group from $32.00 to $33.00 and gave the stock a “buy” rating in a research report on Friday. Citigroup reiterated a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research note on Tuesday, September 29th. Nine investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.25.

Privia Health Group Stock Up 2.0%

The company has a market cap of $3.12 billion, a P/E ratio of 93.93 and a beta of 0.76. The business has a 50-day moving average price of $21.04 and a two-hundred day moving average price of $22.64.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.12. The business had revenue of $656.96 million for the quarter, compared to analysts’ expectations of $610.72 million. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%. The firm’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.29 earnings per share. As a group, sell-side analysts expect that Privia Health Group, Inc. will post 0.27 EPS for the current fiscal year.

Institutional Trading of Privia Health Group

A number of institutional investors have recently bought and sold shares of PRVA. Maryland State Retirement & Pension System grew its stake in shares of Privia Health Group by 64.5% during the third quarter. Maryland State Retirement & Pension System now owns 28,352 shares of the company’s stock worth $558,000 after purchasing an additional 11,114 shares during the period. Illinois Municipal Retirement Fund lifted its stake in Privia Health Group by 5.8% in the third quarter. Illinois Municipal Retirement Fund now owns 60,639 shares of the company’s stock valued at $1,194,000 after buying an additional 3,316 shares during the period. Parallel Advisors LLC lifted its stake in Privia Health Group by 313.7% in the third quarter. Parallel Advisors LLC now owns 2,180 shares of the company’s stock valued at $43,000 after buying an additional 1,653 shares during the period. CenterBook Partners LP acquired a new position in Privia Health Group in the third quarter valued at about $1,152,000. Finally, Heritage Family Offices LLP acquired a new position in Privia Health Group in the third quarter valued at about $34,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.

Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.